Inositol phospho-oligosaccharides (IPOs), which are released from liver membranes upon stimulation by insulin, mimic a wide spectrum of insulin effects in different cells, but not the stimulation of glucose transport. We investigated whether other insulin-sensitive tissues release glucose transport-stimulating IPOs and whether this is related to the human insulin receptor isoform-A or -B (HIR-A or HIR-B 
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INTRODUCTION
Inositol phospho-oligosaccharides (IPOs) isolated from liver and hepatoma cells have similar actions to those of insulin [1] [2] [3] [4] [5] [6] [7] [8] [9] . It has been shown that IPOs that are released from hepatocyte membranes upon insulin stimulation are able to mimic a great number of insulin effects in different cell types [1] [2] [3] [4] [5] [6] [7] [8] [9] . There is increasing evidence that several subclasses of insulin-sensitive IPOs exist [10] . It is believed that these compounds are released from cell membranes due to the stimulation of phospholipase C activity [3] [4] [5] 9] . Since the insulin effect on IPO release was attenuated in cells expressing kinase-negative receptors [9] , it can be assumed that this effect is mediated by the insulin receptor kinase. It is interesting to note that the IPOs from liver are not able to mimic the effect of insulin on glucose transport [1, 4, 6, 9] . We have observed previously that putative IPOs isolated from bovine blood cells by anion-exchange chromatography are able to mimic a similar spectrum of insulin effects [11] as the IPOs from liver and hepatoma cells [1, 2, 4, 9] , and in addition the stimulation ofglucose transport in fat cells [11] has been observed. This finding suggests that glucose-transport-stimulating IPOs do exist, and we speculate that insulin-sensitive tissues other than liver might be able to release certain subclasses of IPOs which are specifically able to stimulate glucose transport. The ability to release these postulated subclasses of IPOs might be a consequence of a tissue-specific composition of plasma membrane glycophospholipids; alternatively, it could be related to the different tissue-specific expression ofthe insulin receptor isoforms (HIR-A and HIR-B). HIR-A and HIR-B might have different abilities to induce the release of specific subclasses, and the lack of glucose transport-stimulating IPOs in liver might be related to the receptor isoform expression, since it is known that liver expresses predominantly HIR-B [12,131. In the present study we have addressed the following questions: (1) do fat cells and ratl-HIR fibroblasts (ratl fibroblasts overexpressing HIR-A or HIR-B) release IPOs upon insulin stimulation, (2) do these IPOs stimulate glucose transport, and (3) are both receptor isotypes able to induce the release of IPOs with the same biological activity?
Merck. Fetal calf serum, Dulbecco's modified Eagle's medium (DMEM)/F12, DMEM, glutamine, PBS and penicillin/streptomycin were from Gibco. Plastic material for cell culture was from Greiner.
Cell culture Ratl fibroblasts transfected with HIR-A (-1.9 x 106 receptors/ cell) or HIR-B (-3.6 x 106 receptors/cell) were cultured in DMEM/F12 supplemented with 10 % fetal calf serum, 2 mM glutamine and penicillin (100 units/ml)/streptomycin (100 ,ug/ ml). For isolation of insulin-mimetic substances, the supernatant of one Petri dish (145 cm2) with a confluent cell layer was used. Prior to stimulation, the medium was removed and the cells were washed three times with PBS, and allowed to stand for 30 min in serum-free DMEM/F12 medium and subsequently in 10 ml of DMEM/F12 with or without 100 nM insulin. After a 10 min incubation at 37°C, the medium was removed from the cell layer and centrifuged to separate remaining cellular particles.
Fat cell preparation
Fat cells were prepared from male Wistar rats according to the method of Rodbell [14] . The epididymal fat pads were digested with collagenase (0.8 mg/ml) in buffer A (125 mM NaCl, 5 mM KCI, 2.5 mM MgCl2, 1 mM CaCl2, 1 mM KH2PO3, 25 mM Tris/HCl, pH 7.4, and 50 mg of BSA/ml). The cells were filtered through a nylon mesh and washed three times. Adipocytes were incubated with 10 nM insulin for 20 min at 37°C in a Krebs/ Ringer/Hepes buffer. Subsequently the buffer was separated from the cells by centrifugation and further processed as described below.
Isolation of insulin-mimetic IPOs For isolation of insulin-mimetic IPOs, 10 ml of the supernatant from 200 x 106 cells was chromatographed in 2 ml AG1X2 anionexchange columns eluted successively with 20 ml of distilled water and three solutions of aqueous HCI adjusted to pH 3, pH 2 and pH 1.3 respectively. The eluates were concentrated, neutralized to pH 7.4 and lyophilized. The lyophilized material was resuspended in 500 pl of water and tested for its ability to stimulate 3-0-methylglucose transport and lipogenesis. 5 ,Ci/ml), ratI-HIR cells were incubated for 12 h with the radioactive material, washed and then incubated for 30 min with serum-free DMEM/F12. IPO release was then stimulated with 100 nM insulin at 37°C for 10 min. The released IPOs were further isolated and purified as described above. For labelling of rat adipocytes, isolated fat cells were incubated in DEM with [3H]glucosamine (5,tCi/ml) and 1 % BSA for 12 h. The medium was removed and adipocytes were washed three times with DEM and then incubated with 10 nM insulin for 20 min at 37 'C. IPOs released from adipocytes were isolated as described above.
3-0-Methylglucose transport In rat adlpocytes Glucose transport was measured as described [16] . Isolated rat adipocytes (epididymal fat) were incubated for 20 min at 37 'C in a Krebs/Ringer/Hepes buffer with 20,l ofpurified IPOs released from ratI fibroblasts or rat adipocytes. Samples (100 4ul) of the concentrated fat cell suspension (12 x Lipogenesis In rat fat cells Lipogenesis was measured by the method of Moody et al. [17] as incorporation of D-[3-3H]glucose into toluene-extractable lipid under conditions where the glucose transport is not rate-limiting [18] . Adipocytes (0.2 ml of cell suspension; 1.5 x 104 cells/ml) were incubated for 60 min at 37°C in buffer A in polypropylene scintillation vials in the presence of tracer glucose, 0.5 mM unlabelled glucose and 10 ll of IPOs released from ratI-HIR fibroblasts or rat adipocytes. The radioactivity in the lipid phase was measured in a liquid scintillation counter.
RESULTS
Transfected ratl fibroblasts IPOs were isolated from ratl fibroblasts overexpressing HIR-A or HIR-B. After incubation in the presence or absence of insulin, the supernatants of these cells were purified as described in the Materials and methods section. Fractions were eluted from an AG1X2 column at pH 3,2 and 1.3. Staining with AGNO3/NaOH was performed as described previously [15] to localize separated oligosaccharides on t.l.c. Figure 1 shows [2, 4, 11, 19] . Table 1 shows the distribution of released radioactivity in fractions from the AG1X2 column eluted at pH 3, pH 2 To determine the biological activity of this material, we tested the AG1X2 fractions for their ability to stimulate 3-0-methylglucose transport and lipogenesis in isolated rat fat cells. Figure  2 shows the stimulation of 3-O-methylglucose uptake with the pH 2 fraction isolated from the supernatant of ratl fibroblasts after treatment or not with insulin. The pH 2 fraction increased 3-O-methylglucose uptake via IPOs released upon insulin stimulation (HIR-A, 2.4-fold stimulation; HIR-B, 2.1-fold stimulation). To assess whether the increased effect observed after insulin stimulation was indeed due to increased IPO release and not to contamination with insulin that had been carried through the purification procedure, we treated the AG1X2 fractions with anti-insulin antibodies. None of the 3-0-methylglucose transport-stimulating activity was lost after the addition of antiinsulin antibodies to the fraction eluted at pH 2, demonstrating that the stimulation is not due to a contamination of this fraction with insulin. As a further control, we added to the basal cell supernatant before the purification procedure, the same insulin concentration that was used in the other experiments to stimulate IPO release by the cells. No bioactivity above the basal value could be found under these conditions in the AG1X2 fraction after the purification procedure (results not shown). These results clearly exclude the possibility that the bioactivity of fibroblasts in the pH 2 fraction is due to contamination by insulin.
To determine whether the insulin-stimulated release of IPOs is induced through the overexpressed HIR-A or HIR-B, or through the parental receptor, we compared parental and transfected cells after stimulation with 100 nM insulin. At this insulin concentration we found no difference between all three cell types. However, earlier studies with cells that have been transfected with the insulin receptor [20, 21] have shown that differences between parental and transfected cells may only be detectable when submaximal insulin concentrations are used. Therefore we repeated the experiments with 0.1 nM insulin. At this insulin concentration, glucose transport was significantly increased (P < 0.01) in transfected cells compared with non-transfected cells (Table 2 ). These results suggest that both receptor isotypes In rat adipocytes IPO release from ratl-HIR fibroblasts was stmulated without (IPO) or with (IS-IPO) 100 nM insulin in serum-free DMEM/F12. The cell supernatant was purified on an AG1X2 anionexchange column. Lipogenesis was stimulated by 10,ul of the lyophilized and resuspended fraction eluted at pH 2 from the AG1X2 column. The hatched bars show the effect of AG1X2 fractions after treatment with anti-insulin antibodies. The basal value (on the left) was determined by addition of Krebs/Ringer/Hepes buffer instead of the AG1X2 pH 2 fraction. The results of five experiments (means ± S.E.M.) are shown.
are able to transduce the insulin signal leading to the release of IPOs. Figure 3 shows the effect ofthe AG1X2 pH 2 fraction from the supernatants of ratl-HIR-A and ratl-HIR-B cells on [3H]glucose incorporation into total lipids of fat cells. The stimulation of lipogenesis was 3.7-fold over basal (the basal value was determined as the effect of IPOs released without insulin stimulation) with fractions from ratl-HIR-A, and 3.8-fold over basal with fractions from ratl-HIR-B. The addition of anti-insulin antibodies did not suppress the effect significantly, demonstrating that no major insulin contamination contributes to stimulation of lipogenesis.
Rat fat cells
To elucidate whether an insulin-dependent release of these insulin-mimetic compounds can only be demonstrated in cells overexpressing the insulin receptor or whether this phenomenon also occurs in rat adipocytes expressing the physiological level of insulin receptors, we stimulated rat adipocytes with insulin and isolated putative IPOs from the incubation buffer, as described for ratl fibroblasts. After labelling of the adipocytes with [3H]glucosamine and incubation with insulin, no significant insulin-induced release oflabelled material was detectable (results not shown). However, the failure to detect insulin-released label in the supernatant might be due to a rapid re-uptake of these compounds by the fat cells, and thus we stimulated IPO release in the presence of 2.5 mM mannose. We have shown previously [11] that mannose is able to block putative IPO uptake in fat cells. In the presence of 2.5 mM mannose, the radioactivity released from [3H]glucosamine-labelled adipocytes after insulin stimulation could be eluted from the AG1X2 column at pH 3 glucosaminelabelled substances were also eluted at pH 2 and pH 3. We tested the biological activity of the AG1X2 fractions from the supernatant of rat adipocytes in the same way as for ratl-HIR fibroblasts, but in the presence of 2.5 mM mannose. Figure 4 shows the effect on 3-O-methylglucose transport of the AG1X2 fractions from supernatant obtained in the presence of mannose from rat adipocytes stimulated or not with insulin. In the absence of insulin, almost no stimulatory activity was found. This is in contrast to the observation with transfected fibroblasts expressing high receptor levels, which released insulin-like activity under basal conditions. In the presence of insulin the stimulation of 3-O-methylglucose uptake (5.9-fold stimulation) could be determined with supernatant from rat adipocytes. The effect on 3-0-methylglucose transport was obtained predominantly with the fraction eluted at pH 1.3, while in ratl-HIR fibroblasts the pH 2 fraction was active. This effect was not suppressed with anti- insulin antibodies. The effect on lipogenesis is shown in Figure 5 . Lipogenesis was stimulated significantly by the IPO fraction eluted at pH 3 (3.2-fold stimulation over the basal value obtained after treatment with anti-insulin antibodies). Approx. 50% of the lipogenesis-stimulating activity could be suppressed by antiinsulin antibodies, suggesting that insulin co-purifies at pH 3 and causes part of the effect on lipogenesis.
DISCUSSION IPO release from ratl fibroblasts overexpressing the human Insulln receptor
The present study shows that ratl fibroblasts overexpressing HIR-A or HIR-B are able to release, upon stimulation by insulin and also under basal conditions, insulin-like activity which activates 3-0-methylglucose uptake and lipogenesis in fat cells. There is some evidence suggesting that the active components of these fractions are IPOs. The arguments for this conclusion are as follows. Throughout the purification protocol the insulin-like activity behaves identically to IPOs isolated by other workers from liver or hepatoma cells [1, 2, 4, 6, 7] and by ourselves from bovine blood [11] . The insulin-like activity is not detectable after nitrous acid treatment, which is compatible with the idea that glucosamine is a part of the active compound [11] . It was demonstrated previously that, in addition to glucosamine mannose also appears to be an important component of insulinmimetic IPOs [11] . [22] . However, we have shown earlier [22] that, in addition to translocation, carrier activation is also required in order to obtain the full stimulation of glucose transport. Substances that were able to mimic the effect ofinsulin on carrier activity included exogenously added phospholipase C or IPOs from bovine blood cells [23] .
IPOs from bovine blood were not able to induce carrier translocation [11] . Taking these earlier findings together with the present observations, we propose that IPOs released from fat cells and ratl-HIR fibroblasts might play a role in the effect of insulin on glucose carrier activity. While the insulin-induced carrier translocation must be an intracellular sequence of reactions, it seems possible that the signal that effects carrier activity might be generated at the cell surface. In this context, a cell-tocell signalling system through IPO release from the cell surface might be involved.
